Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med. 1998;338(16):1089.
Elmore JG, Lee CI. Screening for breast cancer: Evidence for effectiveness and harms. UpToDate. 2021. Accessed at https://www.uptodate.com/contents/screening-for-breast-cancer-evidence-for-effectiveness-and-harms on October 1, 2021.
Hubbard RA, Kerlikowske K, Flowers CI, et al. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: A cohort study. Ann Intern Med 2011;155:481-492.
Lauby-Secretan B, Scoccianti C, Loomis D, et al. Breast-cancer screening--viewpoint of the IARC Working Group. N Engl J Med. 2015;372(24):2353-2358.
Lee CI, Elmore JG. Chapter 10: Breast Cancer Screening. In: Harris JR, Lippman ME, Morrow M, Osborne CK, eds. Diseases of the Breast. 5th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2014.
Puliti D, Duffey SW, Miccinesi G, et al. Overdiagnosis in mammographic screening for breast cancer in Europe: A literature review. J Med Screen, 2012;19:Suppl 1:42-56.
Rosenberg RD, Hunt WC, Williamson MR, et al. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: Review of 183,134 screening mammograms in Albuquerque, New Mexico. Radiology 1998; 209:511–518.
Venkataraman S, Slanetz PJ, Lee CI. Breast imaging for cancer screening: Mammography and
ultrasonography. UpToDate. 2021. Accessed at https://www.uptodate.com/contents/breast-imaging-for-cancer-screening-mammography-and-ultrasonography
on October 1, 2021.